Capital Markets Day took place 3 March 2022 (9.00 am – 5.00 pm CET)
Watch the recorded presentations: Capital Markets Day 2022 (evenzu.com).
Download all presentations from the day collected: Novo Nordisk Capital Markets Day 2022 (pdf). You can also get the individual presentations under each agenda item below.
Presenter:
Lars Fruergaard Jørgensen, Novo
Nordisk President and CEO
Presenter:
Marcus Schindler, CSO and EVP of Research
& Early Development
Presenters:
Camilla Sylvest, EVP Commercial Strategy and
Corporate Affairs
Henrik Wulff, EVP Product Supply, Quality
& IT
Monique Carter, EVP People & Organisation
Karsten Munk Knudsen, EVP and CFO
Please note that the calculation for the list and net price
indexes have been updated on slide 11 in presentation. For insulins,
the list and net prices indexes have been updated across the years,
amounting to index 116 and 40 respectively in 2021. For full
portfolio, the respective numbers in 2021 are index 124 for the list
price and 53 for the net price.
Presenters:
Camilla Sylvest, EVP Commercial Strategy and Corporate
Affairs
Doug Langa, EVP North America
Mike Doustdar, EVP
International Operations
Martin Holst Lange, EVP
Development
Presenters:
Camilla Sylvest, EVP Commercial Strategy and
Corporate Affairs
Henrik Wulff, EVP Product Supply, Quality
& IT
Doug Langa, EVP North America
Mike Doustdar, EVP
International Operations
Martin Holst Lange, EVP Development
Presenters:
Ludovic Helfgott, EVP Rare disease
Martin Holst Lange,
EVP Development
Presenters & panel:
Ludovic Helfgott, EVP Rare
disease
Martin Holst Lange, EVP Development
Camilla
Sylvest, EVP Commercial Strategy and Corporate Affairs
Karsten
Munk Knudsen, EVP and CFO
Format: Break-out session
Presenters:
Marcus Schindler, CSO and EVP of Research
& Early Developement
Karin Conde-Knape, SVP Global drug
discovery
Lars Fogh Iversen, SVP Global research technologies
Format: Break-out session
Presenters:
Frederik Kier, SVP Region North West
Europe
Andrzej Popkowski, SVP Region SEEMEA
Format: Break-out session
Presenters:
Martin Holst Lange, EVP Development
Camilla Sylvest, EVP
Commercial Strategy and Corporate Affairs
Presenters:
Mike Doustdar and EVP International
Operations
Doug Langa, EVP North America
Presenters:
Henrik Wulff, EVP Product Supply,
Quality & IT
Karsten Munk Knudsen, EVP and CFO
Panel Q&A
Closing
Presenter: Lars Fruergaard Jørgensen, Novo Nordisk President and CEO
Investors
Share price
{{priceData.date}} {{priceData.time}}
